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Abstract 
The study was aimed to investigate the growth inhibiting effect of Plectranthus 
amboinicus, (Lour.) Spreng n-hexane extract (PAN) in combination with doxorubicin againts 
HeLa cell Lines, to observe the apoptotic induction and immunocytochemistry of HeLa cell 
Lines on cyclin D1, Bcl-2, and Cox-2 after treatment of PAN. The percentage viability of the 
cell were carried out by using MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium 
bromide] assay. The effect of apoptosis was observed by flowcytometry assay in single dose 
of PAN. The expression of cyclin D1, Bcl2 and COX-2 proteins were investigated on HeLa 
cell lines by using immunocytochemistry. The result showed that PAN showed strong 
synergistic effect with doxorubicin againts HeLa cells based on Combination Index analysis. 
No significant apoptotic induction of PAN in HeLa cell lines, but the extract caused necrosis. 
The immunocytochemical study showed suppression of cyclin D1, Bcl2 and COX-2 
expression on HeLa cell lines. The results concluded that PAN could be a potential co-
chemoterapeutic agent with doxorubicin on cervix cancer cells but need to be explored 
further by its combination on specific molecular target. 
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INTRODUCTION 
 
The latest world report provides clear 
evidence that global cancer rates could increase 
to 15 million by 2020 and is expected to grow 
to 21.4 million new cancer cases and 13.2 
million cancer deaths by 2030. Cancer is one of 
the most life-threathening diseases with more 
than 100 different types. Due to lack of 
effective drugs, expensive cost of 
chemotherapeutic agents and their side effects, 
cancer can be a cause of death. Conventional 
cancer therapies, including surgery and 
chemotherapy have a limited but important role 
in the overall treatment of most solid tumors. 
Chemotherapy drugs are not selective in killing 
cells because they affect the synthesis of 
nucleic acids and protein, so that normal body 
cells also die (MacDonald, et al., 2004).  
Doxorubicin as chemoterapeutic agent 
causes serious problems such as drug resistance 
and toxic effect on normal tissue especially on 
heart. The manifestations are heart failure, 
hypertension, oedema, bradychardi, 
thromboembolisme. Thus the strategies of 
cancer treatment using combined therapies or 
combined agents are considered more 
promising for higher efficacy, and become 
alternative, resulting in a better survival.  
Plant have been source of medicine for 
thousands of years and phytochemicals 
continue to play an essential role in medicine. 
One of the medicinal plant is Plectranthus 
amboinicus (Lour.) Spreng. The previous 
studies had showed that the n-hexane, 
ethylacetate and ethanol extracts of 
Plectranthus amboinicus, (Lour.) Spreng. had 
antioxidant activities.  The n-hexane and  
ethylacetate extracts exhibited strong cytotoxic 
effect  on T47D breast cancer cells with IC50 
value of 44.716 µg/mL and 37.61 µg/mL, 
respectively. Antioxidant activity is usually 
correlated with cancer prevention.  
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Thus, the extract has potential effect as a 
chemoprevention.  The cytotoxic effect of n-
hexane, ethylacetate and ethanol extracts were 
also examined on the HeLa cell lines.The study 
showed that the three extracts had cytotoxic 
effect on HeLa cell with IC50 values 76.322 
µg/mL, 143.291 µg/mL, and 88.997 µg/mL, 
respectively. The aims of this research are to 
investigate cytotoxic activity of PAN-
doxorubicin combination, to analyze apoptotic 
induction and the proteins expression of HeLa 
cell lines after single treatment of PAN. 
 
MATERIALS AND METHODS 
 
Plant Material 
Fresh leaves of Plectranthus 
amboinicus, (Lour.) Spreng. was collected from 
Pematang Siantar, Simalungun regency, 
Sumatera Utara province, Indonesia. 
Plectranthus amboinicus, (Lour.) Spreng. was 
identified in Research Centre for Biology, 
Indonesian Institute of Science, Bogor, and the 
voucher  specimen  was  deposited in 
herbarium. 
   
Preparation of n-Hexane Extract (PAN) 
The air-dried and powdered leaves 
of Plectranthus amboinicus, (Lour.) Spreng. (1 
kg) were repeatedly extracted by cold 
maceration with n-hexane (3x3 d, 7.5 L). The 
powder were dried in the air and extracted with 
ethylacetate (3x3 d, 7.5 L) at room temperature 
on a shake. The filtrate was collected, and then 
evaporated under reduced pressure by rotary 
evaporator (Heidolph VV-200) to obtain a 
viscous extract and the concentrated extract was 
dried by freeze-dryer (Edwards). 
Chemicals: n-hexane and ethylacetate 
were purchased from Merck (Darmstadt, 
Germany), DMSO (Sigma Aldrich Chemie 
GmBH Germany), [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide] (MTT) 
(Sigma Chemical, St. Louis, MO), RPMI media 
and Phosphate Buffer Saline (FBS) 10% v/v 
(Gibco, Grand Island, NY, USA), Doxorubicin 
(Ebewe). 
 
Cytotoxicity Assay 
Cytotoxicity was determined by the MTT 
assay. Briefly, HeLa cells were plated at 10
4
 
cells/well in a 96-well plate. After incubation 
for 24 h at 37
o
C, cells were treated by  
Plectranthus amboinicus n-hexane extract 
(PAN) with different concentration and 
incubated for 24 h. MTT solution was added to 
each well and further incubated for 4h at 37
o
C, 
optical density was read with an ELISA reader 
at 595 nm. 
 
Flowcytometry Assay Apoptosis Assay 
HeLa cells (5x10
5
 cells/well) were 
seeded into 6-well plate and incubated for 24 h. 
After that, the cells were treated with PAN, and 
then incubated for 24 h. Both floating and 
adherent cells were collected in conical tube 
using tripsin 0.025%. The cells were washed 
thrice with cold PBS and centrifuged 2500 rpm 
for 5 min. The supernatant was separated, while 
the sediment was collected and fixed in cold 
70% ethanol in PBS at -20
o
C for 2 h. The cells 
were washed thrice with cold PBS and 
centrifuged in 2500 rpm for 5 min. The 
supernatant was separated, while the sediment 
was collected and fixed in cold 70% ethanol in 
PBS at -20
o
C for 2 h. The cells were washed 
thrice with cold PBS then suspended then 
centrifuged 3000 rpm for 3 min and Annexin V 
kit added to sediment and suspended and 
incubated at 37
o
C for 30 min. The samples 
were analyzed using FACScan flowcytometer. 
 
Immunocytochemistry   
HeLa cells (5x10
4
 cells/well) were 
seeded on coverslips in 24-well plate and 
incubated for 24 h. After that, the cells were 
treated with PAN, and then incubated for 24 h. 
After incubation, the cells were washed with 
PBS and then fixed with cold methanol at 4
o
C 
for 10 min. After that, the cells were washed 
with PBS and blocked in hydrogen peroxide 
blocking solution for 10 min at room 
temperature, incubated using primary antibody 
Bcl-2, cyclin D1, and COX-2 for 1 h, then 
washed thrice with PBS, then incubated with 
secondary antibody for 10 min. The cells were 
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washed with PBS, then incubated in 3,3-
diaminobenzidin (DAB) solution for 10 min, 
and washed with aquadest. Afterward, the cells 
were counterstained with Mayer-Haematoxylin 
for 5 min, and the coverslips were taken and 
washed with aquadest, and then immersed with 
xylol and ethanol 70%. Protein expression 
observed by light microscope (Nikon YS100). 
Cells that express a particular protein will 
provide the brown colour, while the cells that 
does not give a specific protein will provide 
blue colour. 
 
RESULTS AND DISCUSSIONS  
 
The aims of the study were to investigate 
the efficacy of PAN as a co-chemotherapy on 
doxorubicin treatment, to analyze apoptotic 
induction and proteins expression of HeLa cell 
lines after treatment of the extract. PAN, 
doxorubicin and their combination were 
investigated for their cytotoxicity effect on 
HeLa cell lines. Cell viability was determined 
by MTT method after incubation for 24 h, and 
the effect of combination was analyzed by 
Combination Index analysis. The Combination 
Index (CI) analysis is one of the most popular 
method for evaluating drug interactions in 
combination cancer chemotherapy. The method 
is used to categorize the effect of the 
combination which is synergistic, additive, or 
antagonis. In every treatment (PAN and their 
combination) was showed the inhibition of cells 
growth. The IC50 value of PAN 76.322 µg/mL 
and doxorubicin 1.8 µg/mL, and the 
combination was showed higher inhibitory 
effect if compare with single treatment. The 
optimum combination index (synergistic effect) 
was showed in ¼, 
3
/8, and ½  IC50 value of PAN 
and 
1
/2 IC50 value of doxorubicin (0.6 µg/mL) 
categorized with strong synergistic effect (CI < 
0.1). These effects supposed to be related to 
apoptotic induction and expression of some 
proteins. 
In this study, the apoptotic induction and 
expression of proteins were done at PAN single 
treatment, because we wanted to know its effect 
alone. The effect of its combination  with 
doxorubicin need further study. Evaluation of 
apoptotic induction was performed by using 
flowcytometry assay with Annexin V. As 
shown in Fig. 1, the cells in the upper and lower 
right quadrants represent late apoptotic/necrotic 
and early apoptotic cells, respectively. The 
percentage of PAN, in early apoptotic was 
0.20%, in late apoptotic/ early necrotic 11.04% 
and in late necrotic 79.03%. 
The expression of apoptosis regulator 
protein Bcl2, the protein that play important role 
in cell cycle, Cyclin D1, and expression of 
COX-2 which contribute to the development of 
human cancer, were observed in HeLa cells by 
using PAN treatment. COX-2 derived 
prostaglandin E2 induces angiogenesis of tumor 
development by increasing of angiogenic 
factors, or decreased expression of anti-
angiogenic factors, or a combination of both 
event. The effect of PAN on cyclin D1, Bcl2 
and COX-2 expressions were observed by using 
immunocytochemistry. Expression of cyclin 
D1, Bcl2 and COX-2 proteins are positive 
characterized by brown stained nuclei in the 
cells (Fig. 2). 
 
Sample ID: KS APOPT
Patient ID: 1022.14
Acquisition Date: 22-Oct-14
Gate: No Gate
Tota l Events: 20000
Region % Gated % Total
R1 83.75 83.75
R2 6.92 6.92
R3 7.84 7.84
R4 1.65 1.65
Sample ID: KS APOPT
Patient ID: 1022.14
Acquisition Date: 22-Oct-14
Gate: No Gate
Tota l Events: 20000
Quad Location: 121, 62
Quad % Gated % Total
UL 1.66 1.66
UR 7.90 7.90
LL 83.58 83.58
LR 6.86 6.86
R3
R4
R1
 
Sample ID: HEKS 1/5 APOPT
Patient ID: 1022.14
Acquisition Date: 22-Oct-14
Gate: No Gate
Tota l Events: 20000
Region % Gated % Total
R1 10.46 10.46
R2 0.24 0.24
R3 11.00 11.00
R4 78.59 78.59
Sample ID: HEKS 1/5 APOPT
Patient ID: 1022.14
Acquisition Date: 22-Oct-14
Gate: No Gate
Tota l Events: 20000
Quad Location: 121, 62
Quad % Gated % Total
UL 79.03 79.03
UR 11.04 11.04
LL 9.73 9.73
LR 0.20 0.20
R3
R4
R1
 
(A) (B) 
Figure 1. Apoptotic analysis of PAN on HeLa cell lines. (A) control cells; (B) PAN 1/5 IC50 (15.26 
µg/mL) 
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Figure 2. Expression of Bcl2, cyclin D1, and COX-2 after treatment of PAN 1/5 IC50 (15.26 µg/mL) 
observed by immunocytochemistry assay. (A) HeLa control cell; (B) Bcl2 expression; (C) HeLa 
control cell; (D) Cyclin D1 expression; (E) HeLa control cell; (F) COX-2 expression. 
 
The observation of apoptosis regulator 
protein Bcl2 was conducted in HeLa cells after 
treatment of PAN. Immunocytochemistry assay 
with Bcl2 antibody showed the expression of 
Bcl2 was decreased by PAN, therefore it is 
strengthen the apoptosis mechanism of PAN. 
One of secondary metabolite in Plectranthus 
amboinicus is ursolic acid. Ursolic acid inhibit 
EGFR/MAPK and suppress Bcl2 expression on 
colon cancer cell by activation caspase 3 and 9. 
Thus, it is possibly that PAN could induce 
apoptosis through the same pathway, but we 
need further study. As seen in Fig. 2, the 
untreated cells (control) showed high intensity 
for Bcl2, cyclin D1 and COX-2. A single 
treatment of PAN was decreased on Bcl2, 
cyclin D1 and COX-2 expression. Inhibition of 
cyclin D1 protein expression strengthen the 
mechanism of modulating cell cycle especially 
in inhibition of cell cycle on G0-G1 phase. 
Cyclin D1 play important role in G0-G1 phase 
with established complex with CDK-4 or CDK-
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6 to controlled G1 to S phase transition. 
However, we need to be explored more detail 
about the molecular mechanism of apoptosis 
induction, cell cycle modulation, and 
antiangiogenic regulation of PAN. Based on the 
results, it can be concluded that combination of 
n-hexane extract of Plectranthus amboinicus 
(Lour.) Spreng. leaves and doxorubicin 
sinergistically inhibit the HeLa cell lines.  
 
CONCLUSION 
 
Based on the immunocytochemistry 
assays, the n-hexane extract of Plectranthus 
amboinicus can be used in development of 
chemopreventive agent on cervical cancer. 
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